Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
S
018680
vs
K
KOSPI 200
Over the past 12 months, Seoul Pharma Co Ltd has underperformed KOSPI 200, delivering a return of -39% compared to KOSPI 200's +108% growth.
Stocks Performance
018680 vs KOSPI 200
Performance Gap
018680 vs KOSPI 200
Performance By Year
018680 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Seoul Pharma Co Ltd
Glance View
Seoul Pharma Co Ltd is a South Korean drug maker that develops, manufactures, and sells medicines for people. Its product line is centered on prescription drugs and over-the-counter treatments used by hospitals, clinics, pharmacies, and drug distributors. It earns money by selling these medicines through regulated healthcare channels, where buyers care about product quality, safety, and reliable supply. The company’s business is straightforward: it turns pharmaceutical ingredients into finished medicines and moves them into the healthcare market. In this industry, the real value is not just making pills and capsules, but getting approved products into trusted distribution channels and keeping a steady portfolio of treatments that doctors and pharmacists can prescribe or recommend. What makes its role different is that it sits in the middle of the healthcare supply chain as a manufacturer rather than a retailer or hospital operator. That means its results depend on product development, regulatory compliance, manufacturing quality, and relationships with medical institutions and wholesalers, all of which are core to how pharmaceutical businesses compete.